Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Short Interest Update

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) saw a significant growth in short interest in September. As of September 15th, there was short interest totalling 4,200 shares, a growth of 50.0% from the August 31st total of 2,800 shares. Based on an average daily volume of 30,300 shares, the days-to-cover ratio is currently 0.1 days.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Invesco Nasdaq Biotechnology ETF stock. Lake Street Advisors Group LLC purchased a new stake in shares of Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 12,917 shares of the company’s stock, valued at approximately $286,000. Lake Street Advisors Group LLC owned about 0.88% of Invesco Nasdaq Biotechnology ETF at the end of the most recent reporting period.

Invesco Nasdaq Biotechnology ETF Price Performance

Shares of NASDAQ:IBBQ opened at $23.70 on Friday. The company’s fifty day moving average price is $24.01 and its 200-day moving average price is $22.78. Invesco Nasdaq Biotechnology ETF has a one year low of $18.18 and a one year high of $24.84. The firm has a market capitalization of $35.31 million, a price-to-earnings ratio of 17.39 and a beta of 0.61.

Invesco Nasdaq Biotechnology ETF Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, September 27th. Shareholders of record on Monday, September 23rd were paid a dividend of $0.089 per share. The ex-dividend date was Monday, September 23rd. This is an increase from Invesco Nasdaq Biotechnology ETF’s previous quarterly dividend of $0.05. This represents a $0.36 annualized dividend and a dividend yield of 1.50%.

Invesco Nasdaq Biotechnology ETF Company Profile

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.